Department of Liver Surgery, Renji Hospital, Medical College of Shanghai Jiaotong University, China.
FEBS Lett. 2013 Aug 19;587(16):2530-5. doi: 10.1016/j.febslet.2013.06.017. Epub 2013 Jun 19.
WSB-1 is involved in DNA damage response by targeting homeodomain-interacting protein kinase 2 (HIPK2) for ubiquitination and degradation. Here, we report that hypoxia significantly up-regulates the expression of WSB-1 in human hepatocellular carcinoma (HCC) cells. We also provide evidence that WSB-1 is a target of hypoxia-inducible factor 1 (HIF-1). Silencing the expression of HIF-1α in HCC cells by RNA interference abolishes hypoxia-induced WSB-1 expression. Using chromatin immunoprecipitation and luciferase reporter assays, we identified a HRE of the WSB-1 gene. Moreover, silencing the expression of WSB-1 by RNA interference rescues HIPK2 expression in hypoxic HCC cells and promotes etoposide-induced cell death in hypoxic HCC cells. Taken together, these data shed light on the mechanisms underlying hypoxia-induced chemoresistance in HCC cells.
WSB-1 通过靶向同源结构域相互作用蛋白激酶 2(HIPK2)的泛素化和降解参与 DNA 损伤反应。在这里,我们报告低氧显著上调人肝癌(HCC)细胞中 WSB-1 的表达。我们还提供证据表明 WSB-1 是缺氧诱导因子 1(HIF-1)的靶标。用 RNA 干扰沉默 HCC 细胞中 HIF-1α 的表达可消除低氧诱导的 WSB-1 表达。通过染色质免疫沉淀和荧光素酶报告基因分析,我们鉴定了 WSB-1 基因的 HRE。此外,用 RNA 干扰沉默 WSB-1 的表达可挽救低氧 HCC 细胞中 HIPK2 的表达,并促进低氧 HCC 细胞中依托泊苷诱导的细胞死亡。总之,这些数据阐明了 HCC 细胞中低氧诱导的化疗耐药的机制。